1 min read

ID: 120096

Discovery Date: 10 May 2022, 08:45:06 UTC

Published Date: NaT

Source: European Clinical Trials Register

Link: https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2021-005746-15

Abstract

EudraCT Number: 2021-005746-15
Sponsor Protocol Number: MN43964
Sponsor Name: Roche Farma S. A. U. que realiza el ensayo en España y que actúa como representante F. Hoffmann-La Roche Ltd
Start Date: 2022-05-09
Medical condition: Primary Progressive Multiple Sclerosis (PPMS) Relapsing Multiple Sclerosis (RMS)
Disease:
Version: 21.1
SOC Term: 10029205 - Nervous system disorders
Classification Code: 10063399
Term: Relapsing-remitting multiple sclerosis
Level: PT
Version: 21.1
SOC Term: 10029205 - Nervous system disorders
Classification Code: 10063401
Term: Primary progressive multiple sclerosis
Level: PT

Population Age: Adults
Gender: Male, Female
Trial Protocol: ES (Ongoing)

Noun Phrases in Title

This is an independent project that runs on the good will of volunteers

You can help by spreading the word or by donating what you can to pay for the server costs.